Loss of ribosomal protein uL14 enables tumor escape from T cell immunosurveillance.

IF 3.2 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
NAR cancer Pub Date : 2025-08-30 eCollection Date: 2025-09-01 DOI:10.1093/narcan/zcaf024
Anna Dopler, Edwin S Kyei-Baffour, Mandy Kerkhoff, Ferhat Alkan, Yuval Malka, Kelly Hoefakker, Rob van der Kammen, Liesbeth Hoekman, Onno Bleijerveld, Antonia Bradaric, Maarten Altelaar, Jonathan W Yewdell, Pia Kvistborg, William J Faller
{"title":"Loss of ribosomal protein uL14 enables tumor escape from T cell immunosurveillance.","authors":"Anna Dopler, Edwin S Kyei-Baffour, Mandy Kerkhoff, Ferhat Alkan, Yuval Malka, Kelly Hoefakker, Rob van der Kammen, Liesbeth Hoekman, Onno Bleijerveld, Antonia Bradaric, Maarten Altelaar, Jonathan W Yewdell, Pia Kvistborg, William J Faller","doi":"10.1093/narcan/zcaf024","DOIUrl":null,"url":null,"abstract":"<p><p>The presentation of peptides on HLA molecules is essential to CD8<sup>+</sup> T cell responses. Here, we show that loss of uL14 significantly downregulates the expression of antigen processing and presentation (APP) components in melanoma cell lines. Peptides generated following knockdown show different characteristics, with altered peptide charge, and differences in anchor residue positions. These peptides also have lower predicted binding to the HLA alleles and a shorter predicted HLA-peptide complex half-life. These result in a functional difference in APP, and knockdown of uL14 causes a reduction in the ability of CD8<sup>+</sup> T cells to recognize and kill melanoma cells in a co-culture assay. Together, our data suggest that loss of uL14 alters the peptide pool available for presentation and thus may act as an escape mechanism from tumor immune surveillance.</p>","PeriodicalId":94149,"journal":{"name":"NAR cancer","volume":"7 3","pages":"zcaf024"},"PeriodicalIF":3.2000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12409406/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAR cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/narcan/zcaf024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The presentation of peptides on HLA molecules is essential to CD8+ T cell responses. Here, we show that loss of uL14 significantly downregulates the expression of antigen processing and presentation (APP) components in melanoma cell lines. Peptides generated following knockdown show different characteristics, with altered peptide charge, and differences in anchor residue positions. These peptides also have lower predicted binding to the HLA alleles and a shorter predicted HLA-peptide complex half-life. These result in a functional difference in APP, and knockdown of uL14 causes a reduction in the ability of CD8+ T cells to recognize and kill melanoma cells in a co-culture assay. Together, our data suggest that loss of uL14 alters the peptide pool available for presentation and thus may act as an escape mechanism from tumor immune surveillance.

Abstract Image

Abstract Image

Abstract Image

核糖体蛋白uL14的缺失使肿瘤逃避T细胞免疫监视。
HLA分子上多肽的呈现对CD8+ T细胞应答至关重要。在这里,我们发现uL14的缺失显著下调了黑色素瘤细胞系中抗原加工和递呈(APP)成分的表达。敲除后产生的肽具有不同的特征,肽电荷改变,锚位点位置不同。这些肽与HLA等位基因的结合预期较低,预测HLA-肽复合物的半衰期较短。这些导致APP的功能差异,在共培养实验中,uL14的敲低导致CD8+ T细胞识别和杀死黑色素瘤细胞的能力降低。总之,我们的数据表明,uL14的缺失改变了可用于呈递的肽库,因此可能作为逃避肿瘤免疫监视的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信